BIOM3 Stock Chart & Stats
$5.51
-$0.28(-4.84%)
―
--
Day’s Range― - ―
52-Week Range$4.82 - $10.39
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
R$754.06M
Enterprise ValueN/A
Total Cash (Recent Filing)R$30.82M
Total Debt (Recent Filing)R$89.90M
Price to Earnings (P/E)34.4
Beta-0.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.16
Shares Outstanding136,852,480
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio1.52
Price to Book (P/B)2.98
Price to Sales (P/S)3.47
P/FCF Ratio-6.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BIOM3 FAQ
What was Biomm SA’s price range in the past 12 months?
Biomm SA lowest stock price was $4.82 and its highest was $10.39 in the past 12 months.
What is Biomm SA’s market cap?
Biomm SA’s market cap is R$754.06M.
When is Biomm SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biomm SA’s earnings last quarter?
Currently, no data Available
Is Biomm SA overvalued?
According to Wall Street analysts Biomm SA’s price is currently Undervalued.
Does Biomm SA pay dividends?
Biomm SA does not currently pay dividends.
What is Biomm SA’s EPS estimate?
Biomm SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biomm SA have?
Biomm SA has 136,852,480 shares outstanding.
What happened to Biomm SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biomm SA?
Currently, no hedge funds are holding shares in BR:BIOM3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biomm SA
Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product portfolio features pharmaceutical and healthcare solutions, including AFREZZA, a human insulin administered as an inhalation powder, and GLARGILIN, a type of glargine insulin. The company also supplies HERZUMA, a trastuzumab, and CONFORT CARE, a moisturizing foot cream. Biomm S.A. was established in 2001 and maintains its headquarters in São Paulo, Brazil.
D1000 Varejo Farma Participacoes SA
―
Ourofino S.A.
―
Oncoclinicas do Brasil Servicos Medicos SA
―
Profarma Distribuidora de Produtos Farmaceuticos SA
―
Empreendimentos Pague Menos SA
―